It is a pharma private limited company based in Haveli, Maharashtra, India, established in 2010.
2010 | Haveli, Maharashtra, India | ActiveAcclimate Pharmaceuticals Private Limited, a active private limited company, was established on 15 June 2010 in Haveli, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U15137PN2010PTC136578. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.
Formerly known as Acclimate Management Consultants Private Limited. It upholds a compliant status. Its leadership includes Appa Khandu Makhar (Director), Ujwala Raju Pote (Director). Past directors included Appa Khandu Makhar, Nitin Purushottam Umalkar, Ujwala Raju Pote. It holds no open charges and ₹1.28 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No.3, B-304, Shekhar Paradise, Plot No.3, Sector No.9, Pcntda, Moshi, Haveli, Maharashtra, 412105.
U15137PN2010PTC136578
136578
15 June 2010
₹0.60 M
₹0.60 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Acclimate Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Appa Khandu Makhar | Director | 25 Mar 2024 | Current |
| Ujwala Raju Pote | Director | 25 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 20 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 25 Mar 2024 | Past |
| Pramod Abcsdd | Director | 25 Mar 2024 | Past |
| Pramod Abcsdd | Director | 29 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Acclimate Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.56% decrease. The company also saw a substantial improvement in profitability, with a 85.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Acclimate Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,278,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2017 | Idbi Bank Limited | ₹1.28 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Acclimate Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Acclimate Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acclimate Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Acclimate Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Acclimate Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Appa Khandu Makhar was appointed as a Director was appointed as a Director on 25 Mar 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The activity Ujwala Raju Pote was appointed as a Director was appointed as a Director on 25 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
The activity A charge registered on 28 Apr 2017 via Charge ID 100096982 with Idbi Bank Limited was fully satisfied on 20 Nov 2020. was completed.
Progress on A charge with Idbi Bank Limited of Rs. 1.28 M registered on 28 Apr 2017 with Charge ID 100096982 was modified on 21 Jun 2018. was documented.
The CIN of Acclimate Pharmaceuticals Private Limited is U15137PN2010PTC136578.
Acclimate Pharmaceuticals Private Limited is headquartered at Office No.3, B-304, Shekhar Paradise, Plot No.3, Sector No.9, Pcntda, Moshi, Haveli, Maharashtra, 412105.
Acclimate Pharmaceuticals Private Limited was incorporated on 15 June 2010.
The current directors of Acclimate Pharmaceuticals Private Limited are
The primary industry of Acclimate Pharmaceuticals Private Limited is Trade.
Acclimate Pharmaceuticals Private Limited is unlisted.
The authorized capital of Acclimate Pharmaceuticals Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.
The compliance status of Acclimate Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX